drugset / Trial / NCT01884831

The Study of the Effectiveness of Tissue Equivalent on the Basis of Cultured Cells to Heal Skin Blemishes

NCT01884831 ↗

Phase 2 Unknown 1 enrolled Ural State Medical University
NaSingle-groupDouble-blindTreatment

Summary

In Russia the treatment nonhealing skin defects often limited to surgical interventions, despite having developed modern methods of treatment of non-healing ulcers and other skin imperfections. During the many years of research we have developed a skin equivalent comprising living cells. During pilot trial showed that the skin equivalent provides healing skin defect within 1-4 weeks in 95% of patients.

Timeline

Start
2014-02
Primary completion
2017-07
Completion
2018-07

Drugs

EvaluationDrugModalityDoseRoute
Subject skin equivalent Cell therapy — —